These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
59 related articles for article (PubMed ID: 1831701)
1. [Effect of human fibroblast derived inhibitor on tumor and transformed cell proliferation and differentiation]. Song Y; Wu K Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1991 Feb; 13(1):50-5. PubMed ID: 1831701 [TBL] [Abstract][Full Text] [Related]
2. [Significance and modulation of production of tumor growth inhibitor derived from human embryonic myofibroblasts]. Wu KF Zhonghua Zhong Liu Za Zhi; 1989 Nov; 11(6):419-21. PubMed ID: 2699449 [TBL] [Abstract][Full Text] [Related]
3. Effects of recombinant human tumor necrosis factor on highly enriched hematopoietic progenitor cell populations from normal human bone marrow and peripheral blood and bone marrow from patients with chronic myeloid leukemia. Wisniewski D; Strife A; Atzpodien J; Clarkson BD Cancer Res; 1987 Sep; 47(18):4788-94. PubMed ID: 3040231 [TBL] [Abstract][Full Text] [Related]
4. Inhibition of the ABL kinase activity blocks the proliferation of BCR/ABL+ leukemic cells and induces apoptosis. Gambacorti-Passerini C; le Coutre P; Mologni L; Fanelli M; Bertazzoli C; Marchesi E; Di Nicola M; Biondi A; Corneo GM; Belotti D; Pogliani E; Lydon NB Blood Cells Mol Dis; 1997 Dec; 23(3):380-94. PubMed ID: 9446752 [TBL] [Abstract][Full Text] [Related]
5. 20-Cyclopropyl-cholecalciferol vitamin D3 analogs: a unique class of potent inhibitors of proliferation of human prostate, breast and myeloid leukemia cell lines. Koike M; Koshizuka K; Kawabata H; Yang R; Taub HE; Said J; Uskokovic M; Tsuruoka N; Koeffler HP Anticancer Res; 1999; 19(3A):1689-97. PubMed ID: 10470102 [TBL] [Abstract][Full Text] [Related]
6. 24-Oxo metabolites of vitamin D3 analogues: disassociation of their prominent antileukemic effects from their lack of calcium modulation. Shiohara M; Uskokovic M; Hisatake J; Hisatake Y; Koike K; Komiyama A; Koeffler HP Cancer Res; 2001 Apr; 61(8):3361-8. PubMed ID: 11309293 [TBL] [Abstract][Full Text] [Related]
7. Effects of combinations of transforming growth factor-beta 1 and tumor necrosis factor on induction of differentiation of human myelogenous leukemic cell lines. Kamijo R; Takeda K; Nagumo M; Konno K J Immunol; 1990 Feb; 144(4):1311-6. PubMed ID: 2105994 [TBL] [Abstract][Full Text] [Related]
10. Effects of flt3 ligand on acute myeloid and lymphocytic leukemic blast cells from children. McKenna HJ; Smith FO; Brasel K; Hirschstein D; Bernstein ID; Williams DE; Lyman SD Exp Hematol; 1996 Feb; 24(2):378-85. PubMed ID: 8641369 [TBL] [Abstract][Full Text] [Related]
11. Production by undifferentiated myeloid leukemia cells of a novel growth-inhibitory factor(s) for partially differentiated myeloid leukemic cells. Kasukabe T; Okabe-Kado J; Honma Y; Hozumi M Jpn J Cancer Res; 1987 Sep; 78(9):921-31. PubMed ID: 3117748 [TBL] [Abstract][Full Text] [Related]
12. Human bone marrow fibroblastic cells can inhibit clonogenic growth of K562 cells. Noguchi K; Nagao T; Arimori S Tokai J Exp Clin Med; 1985 Oct; 10(5):537-43. PubMed ID: 3870061 [TBL] [Abstract][Full Text] [Related]
13. A fraction isolated from Ehrlich ascites carcinoma as an antitumor and differentiating agent against human leukemic cell ML-2. Sur P; Nandi N; Ghosh P; Ghosh NC Neoplasma; 2000; 47(2):114-7. PubMed ID: 10985477 [TBL] [Abstract][Full Text] [Related]
14. Effects of transforming growth factor beta, tumor necrosis factor alpha, interferon gamma and LIF-HILDA on the proliferation of acute myeloid leukemia cells. Kerangueven F; Sempere C; Tabilio A; Mannoni P Eur Cytokine Netw; 1990; 1(2):99-107. PubMed ID: 2129395 [TBL] [Abstract][Full Text] [Related]
15. Effect of retinoic acid on the clonal growth of childhood myeloid and lymphoid leukemias: a pediatric oncology group study. Findley HW; Steuber CP; Ruymann FB; Culbert S; Ragab AH Exp Hematol; 1984 Nov; 12(10):768-73. PubMed ID: 6334611 [TBL] [Abstract][Full Text] [Related]
16. Effects of bone marrow fibroblasts on the proliferation and differentiation of myeloid leukemic cell lines. Stolze B; Emmendörffer A; Corbacioglu S; König A; Welte K; Ebell W Exp Hematol; 1995 Dec; 23(13):1378-87. PubMed ID: 7498367 [TBL] [Abstract][Full Text] [Related]
17. TPA induces differentiation of purified human myeloblasts in the absence of proliferation. Griffin JD; Larcom P; Kufe DW Exp Hematol; 1985 Nov; 13(10):1025-32. PubMed ID: 3932087 [TBL] [Abstract][Full Text] [Related]
18. Tumor growth inhibition induced in a murine model of human Burkitt's lymphoma by a proteasome inhibitor. Orlowski RZ; Eswara JR; Lafond-Walker A; Grever MR; Orlowski M; Dang CV Cancer Res; 1998 Oct; 58(19):4342-8. PubMed ID: 9766662 [TBL] [Abstract][Full Text] [Related]
19. IP6-induced growth inhibition and differentiation of HT-29 human colon cancer cells: involvement of intracellular inositol phosphates. Yang GY; Shamsuddin AM Anticancer Res; 1995; 15(6B):2479-87. PubMed ID: 8669811 [TBL] [Abstract][Full Text] [Related]
20. Induction of differentiation of human myeloid leukemia cells by 2'-deoxycoformycin in combination with 2'-deoxyadenosine. Niitsu N; Umeda M; Honma Y Biochem Biophys Res Commun; 1997 Sep; 238(1):100-6. PubMed ID: 9299460 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]